Neos Therapeutics OverviewNeos Therapeutics Cost of Revenue
Cost of Revenue analysis for NEOS.
Quarterly Cost of Revenue
$5.12M
↓ 20.58% YoY
As of Sep 30, 2020
Annual Cost of Revenue (TTM)
$24.57M
↓ 4.42% YoY
Trailing 12 months ending Sep 30, 2020
Neos Therapeutics OverviewCost of Revenue analysis for NEOS.
As of Sep 30, 2020
Trailing 12 months ending Sep 30, 2020